a crazy basket case - case study rsv adult

Category

case study rsv adult - a crazy basket case


RSV can also become serious in older adults, adults with heart and lung diseases, or anyone with a very weak immune system (immunocompromised) (Welliver et. al., ). A new study will expose healthy adult volunteers to respiratory syncytial virus (RSV), a virus that causes cold-like symptoms in adults. Better understanding of how adults develop RSV infection and immune system responses to infection will assist researchers in developing and testing future antivirals and vaccines to combat the virus.

Sep 10,  · As many of the studies on RSV in adults were case series, we included only those with more than 10 patients. Because this was not a formal systematic review, we did not grade the included studies but summarized key outcomes or xxxcum.xyz by: Jul 01,  · RSV is thought to be an underrecognized pathogen in older adults, based on case reports of RSV pneumonia, studies of adults with respiratory disease requiring hospitalization, and epidemiological studies from the United xxxcum.xyz by:

Aug 10,  · In multiple studies, medically attended–RSV incidence among older adults not selected for having underlying health conditions increased with increasing age. Of prospectively followed lung transplant recipients, 16% tested positive for RSV. May 11,  · The patient in this case study was infected with RSV, and the disease progressed rapidly, with extensive cerebral edema and hernia. There are prior reports of neurological complications of RSV infection, which mainly include central apnea, seizures, and encephalopathy [ 10 ].

In , infants and toddlers immunized with a formalin-inactivated vaccine against respiratory syncytial virus (RSV) experienced an enhanced form of RSV disease characterized by high fever, bronchopneumonia, and wheezing when they became infected with wild-type virus in the community. Hospitalizations were frequent, and two immunized toddlers died upon infection with wild-type RSV. The investiGational RSV mAternal vacCinE study (GRACE) is a double-blind phase 3 study (NCT) to be conducted in up to 10, pregnant women aged years.